Nordhealth AS (OSL:NORDH)
Norway · Delayed Price · Currency is NOK 23.60
0.00 (0.00%)
Aug 4, 2026, 4:25 PM CET
Nordhealth AS Financials Overview
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 50.84 | 50.84 | 45.68 | 36.83 | 31.05 | 20.3 |
Revenue Growth | 11.31% | 11.31% | 24.03% | 18.60% | 52.95% | 60.04% |
Gross Profit Gross Profit Growth | 41.3 | 41.3 | 39.03 | 31.65 | 26.27 | 16.74 |
Operating Income Operating Income Growth | -12.47 | -12.47 | -7.73 | -11.39 | -14.68 | -4.46 |
Net Income Net Income Growth | -12.68 | -12.68 | -7.67 | -11.13 | -14.26 | -4.73 |
Earnings Per Share EPS Growth | -0.16 | -0.16 | -0.10 | -0.14 | -0.18 | -0.06 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Veterinary Veterinary Growth | 33.15 | 28.43 | 20.59 | 15.47 | 11.63 |
Therapy Therapy Growth | 16.3 | 15.44 | 14.45 | 15.58 | 8.67 |
Other Other Growth | 1.39 | 1.8 | 1.78 | - | - |
Total Total Growth | 50.84 | 45.68 | 36.83 | 31.05 | 20.3 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 14.7 | 14.7 | 19.62 | 22.17 | 39.2 | 72.67 |
Total Debt Total Debt Growth | 0 | 0 | 0 | 0 | 0.03 | 0.05 |
Net Cash (Debt) Net Cash Growth | 14.7 | 14.7 | 19.62 | 22.17 | 39.17 | 72.62 |
Net Cash Growth | -25.07% | -25.07% | -11.50% | -43.40% | -46.06% | 3986.55% |
Net Cash Per Share Net Cash Per Share Growth | 0.19 | 0.19 | 0.24 | 0.28 | 0.49 | 0.91 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 0.72 | 0.72 | 1.85 | -5.22 | -6.53 | 5.57 |
Capital Expenditures CapEx Growth | -5.09 | -5.09 | -5.02 | -5.72 | -6.8 | -3.38 |
Free Cash Flow Free Cash Flow Growth | -4.37 | -4.37 | -3.17 | -10.95 | -13.33 | 2.19 |
Free Cash Flow Growth | - | - | - | - | - | -25.51% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 81.23% | 81.23% | 85.44% | 85.96% | 84.60% | 82.45% |
Operating Margin | -24.53% | -24.53% | -16.92% | -30.92% | -47.27% | -21.96% |
Pretax Margin | -24.18% | -24.18% | -14.53% | -29.34% | -45.50% | -22.89% |
Profit Margin | -24.94% | -24.94% | -16.80% | -30.23% | -45.94% | -23.31% |
FCF Margin | -8.60% | -8.60% | -6.94% | -29.72% | -42.92% | 10.79% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | - | 44.38 | 150.51 | 52.81 | 52.81 | 94.36 |
P/FCF Ratio | - | - | - | - | - | 146.36 |
PS Ratio | 3.20 | 4.86 | 6.61 | 4.75 | 5.48 | 15.79 |